- Home
- NOMD vs ARWR Comparison
NOMD vs ARWR Comparison
Compare NOMD & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOMD
- ARWR
- Stock Information
- Founded
- NOMD 2014
- ARWR 2003
- Country
- NOMD United Kingdom
- ARWR United States
- Employees
- NOMD N/A
- ARWR N/A
- Industry
- NOMD Packaged Foods
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- NOMD Consumer Staples
- ARWR Health Care
- Exchange
- NOMD Nasdaq
- ARWR Nasdaq
- Market Cap
- NOMD 2.7B
- ARWR 2.6B
- IPO Year
- NOMD N/A
- ARWR 1993
- Fundamental
- Price
- NOMD $18.86
- ARWR $19.90
- Analyst Decision
- NOMD Strong Buy
- ARWR Buy
- Analyst Count
- NOMD 3
- ARWR 11
- Target Price
- NOMD $22.00
- ARWR $43.33
- AVG Volume (30 Days)
- NOMD 582.9K
- ARWR 2.5M
- Earning Date
- NOMD 03-03-2025
- ARWR 02-10-2025
- Dividend Yield
- NOMD 3.64%
- ARWR N/A
- EPS Growth
- NOMD 4.33
- ARWR N/A
- EPS
- NOMD 1.37
- ARWR N/A
- Revenue
- NOMD $3,420,923,487.00
- ARWR $2,500,000.00
- Revenue This Year
- NOMD $3.79
- ARWR $3,336.78
- Revenue Next Year
- NOMD $2.63
- ARWR $124.29
- P/E Ratio
- NOMD $13.37
- ARWR N/A
- Revenue Growth
- NOMD 1.10
- ARWR N/A
- 52 Week Low
- NOMD $15.43
- ARWR $17.05
- 52 Week High
- NOMD $20.05
- ARWR $36.72
- Technical
- Relative Strength Index (RSI)
- NOMD 68.24
- ARWR 49.40
- Support Level
- NOMD $17.64
- ARWR $17.57
- Resistance Level
- NOMD $18.44
- ARWR $21.84
- Average True Range (ATR)
- NOMD 0.48
- ARWR 1.06
- MACD
- NOMD 0.08
- ARWR 0.11
- Stochastic Oscillator
- NOMD 96.91
- ARWR 54.57
About NOMD Nomad Foods Limited
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals. It sells its products primarily through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.